Burst Spinal Cord Stimulation for Neuropathic Pain

Antwerp University Hospital (UZA)

Status: Completed

Conditions: Neuropathic Pain

Treatments: Procedure: dorsal column stimulator

Study type: Interventional

Funder types: Other

Identifiers

NCT01486108

burst spinal cord stimulation

Details and patient eligibility

About

Recently a novel stimulation design was developed, called burst stimulation. In a non-placebo controlled pilot study burst stimulation seemed superior to tonic stimulation over a period extending more than 2 years, and even though an incidental finding, this design seemed capable of suppressing pain without mandatory induction of paresthesias. This permits for the first time to scientifically prove that spinal cord stimulation is better than placebo stimulation. A study was therefore initiated to find out whether spinal cord stimulation is indeed capable of suppressing neuropathic limb pain in a placebo controlled way.

Full description

Patients receive three type of stimulation (burst, tonic and sham). We want to compare these different stimulation protocol to verify which one is the one the patient prefer the most and have the least side-effects (paresthesia)

Enrollment: 15 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

All patients were selected after multidisciplinary discussion with a specialized pain physician, a psychological and psychiatric evaluation was performed to rule out psychogenic pain as well as other psychiatric morbidity contraindicating an implant. After authorization by the psychologist and psychiatrist an implant was offered.

Inclusion Criteria

• Patients enrolled in this study must meet the following inclusion criteria:
• Patients able to provide informed consent to participate in the study;
• Patient is between the age of 18 and 75;
• Patient has Failed Back Surgery Syndrome;
• Patient has a simulator implanted at the dorsal column spinal cord powered by an EON/EON Mini® internal pulse generator.
• Patient medication has remained stable for at least 4 weeks prior to baseline data collection;
• Patient agrees not to add or increase medication throughout the randomization trial period of the study;
• Patient is willing to cooperate with the study requirements including compliance with the treatment regimen and completion of all office visits.

Exclusion Criteria

A patient will be excluded from participation in this study if they meet any one of the following criteria:

• Patient has current evidence of any psychiatric disorder, as documented by the DSM-IV-TR criteria with psychotic characteristics;
• Patient has a history of life-threatening severe illness or is suffering from severe chronic disease other than the indication for the study;
• Patient has history of substance abuse or substance dependency in the past 6 months prior to baseline data collection;
• Patient currently participating in another clinical study;
• Patient with demand-type cardiac pacemakers, an infusion pump or any other implantable neurostimulator device except for the spinal cord stimulator under study;
• Patient is not willing to maintain current medication regimen;
• Female candidates of child bearing potential who are pregnant (confirmed by positive urine/blood pregnancy test), not using adequate contraception as determined by the investigator, or nursing (lactating) a child.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: Quadruple Blind

---

15 participants in 3 patient groups

Tonic

Experimental group

Description:

5 hz stimulation at an amplitude that the patient find bearable (+/- 1.5 mA)

Treatment:

Procedure: dorsal column stimulator

Sham

Experimental group

Description:

no stimulation, patient receive a sham stimulation (actually the IPG is not running)

Treatment:

Procedure: dorsal column stimulator

burst

Experimental group

Description:

500 hz burst at 5 hz stimulation

Treatment:

Procedure: dorsal column stimulator